University of Illinois College of Medicine at Peoria Pediatrics

Topics

• Platelet Disorders and Treatments 79
• Hemophilia Treatment and Research 48
• Congenital Heart Disease Studies 33
• Allergic Rhinitis and Sensitization 25
• Central Venous Catheters and Hemodialysis 23
• Gastrointestinal motility and disorders 22
• Hemoglobinopathies and Related Disorders 21
• Lymphoma Diagnosis and Treatment 20
• Asthma and respiratory diseases 13
• Obesity, Physical Activity, Diet 13
• Tuberculosis Research and Epidemiology 13
• Kawasaki Disease and Coronary Complications 12

Most cited

1. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.

   The Lancet. Neurology · 2021 · 399 citations · Deepa Chand

2. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.

   American journal of hematology · 2021 · 324 citations · Michael Tarantino

3. Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy.

   Journal of hepatology · 2021 · 248 citations · Deepa Chand

4. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial.

   The Lancet. Neurology · 2021 · 228 citations · Deepa Chand

5. Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series.

   The Journal of pediatrics · 2021 · 173 citations · Deepa Chand

6. Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients.

   American journal of respiratory and critical care medicine · 2024 · 38 citations · Sarah Chalmers